A detailed history of Great Diamond Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Great Diamond Partners, LLC holds 8,452 shares of ABBV stock, worth $1.52 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
8,452
Previous 10,164 16.84%
Holding current value
$1.52 Million
Previous $1.74 Million 4.25%
% of portfolio
0.43%
Previous 0.42%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$163.84 - $199.33 $280,494 - $341,252
-1,712 Reduced 16.84%
8,452 $1.67 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $103,090 - $120,386
-666 Reduced 6.15%
10,164 $1.74 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 0.01%
10,830 $1.97 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $28,070 - $31,613
204 Added 1.92%
10,829 $1.68 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $22,843 - $26,445
171 Added 1.64%
10,625 $1.58 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $63,869 - $79,481
-482 Reduced 4.41%
10,454 $1.41 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $128,413 - $147,887
-888 Reduced 7.51%
10,936 $1.74 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $42,046 - $50,424
304 Added 2.64%
11,824 $1.91 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $536,571 - $615,412
3,998 Added 53.15%
11,520 $1.55 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $16,927 - $21,520
123 Added 1.66%
7,522 $1.15 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $4,091 - $5,076
31 Added 0.42%
7,399 $1.2 Million
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $68,862 - $87,131
641 Added 9.53%
7,368 $997,000
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $227,057 - $257,744
2,134 Added 46.46%
6,727 $725,000
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $2,209 - $2,461
-21 Reduced 0.46%
4,593 $517,000
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $2,148 - $2,365
21 Added 0.46%
4,614 $499,000
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $4,024 - $5,433
-50 Reduced 1.08%
4,593 $492,000
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $2,405 - $2,823
28 Added 0.61%
4,643 $406,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $1,614 - $2,159
22 Added 0.48%
4,615 $453,000
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $331,293 - $414,518
4,593 New
4,593 $406,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.